{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T02:26:34Z","timestamp":1786242394135,"version":"build-2736575974"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.tiv.2025.106019","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:44:45Z","timestamp":1738889085000},"page":"106019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["In vitro human skin absorption of ethyl salicylate, pentyl salicylate, and (Z)-3-hexenyl salicylate from topical formulations: Effects on permeation and distribution"],"prefix":"10.1016","volume":"104","author":[{"given":"Kaushal","family":"Joshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren M.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Christian","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie E.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie G.","family":"Stocks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna P.","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Api","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2025.106019_bb0005","series-title":"Common Fragrance and Flavor Materials\u202f: Preparation, Properties, and Uses. VCH Verlagsgesellschaft; Distribution USA and Canada","author":"Bauer","year":"1985"},{"issue":"Suppl. 1","key":"10.1016\/j.tiv.2025.106019_bb0010","doi-asserted-by":"crossref","first-page":"S318","DOI":"10.1016\/j.fct.2007.09.066","article-title":"A toxicologic and dermatologic assessment of salicylates when used as fragrance ingredients","volume":"45","author":"Belsito","year":"2007","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.tiv.2025.106019_bib86","doi-asserted-by":"crossref","first-page":"121826","DOI":"10.1016\/j.ijpharm.2022.121826","article-title":"In vitro human skin absorption of linalool: Effects of vehicle composition, evaporation and occlusion on permeation and distribution","volume":"622","author":"Brain","year":"2022","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1016\/j.tiv.2025.106019_bb0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tiv.2006.08.005","article-title":"In-vitro human skin penetration of the fragrance material geranyl nitrile","volume":"21","author":"Brain","year":"2007","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2025.106019_bb0020","series-title":"Call for data on ingredients used in cosmetic products","author":"EC","year":"2022"},{"issue":"10","key":"10.1016\/j.tiv.2025.106019_bib87","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0278-6915(92)90056-Q","article-title":"Percutaneous absorption of nicotinic acid, phenol, benzoic acid and triclopyr butoxyethyl ester through rat and human skin in vitro: further validation of an in vitro model by comparison with in vivo data","volume":"30","author":"Hotchkiss","year":"1992","journal-title":"Food Chem Toxicol"},{"issue":"4","key":"10.1016\/j.tiv.2025.106019_bb0030","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jaad.2013.12.005","article-title":"A review of toxicity from topical salicylic acid preparations","volume":"70","author":"Madan","year":"2014","journal-title":"J. Am. Acad. Dermatol."},{"issue":"7","key":"10.1016\/j.tiv.2025.106019_bb0035","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s00204-024-03749-8","article-title":"In vitro to in vivo extrapolation to derive a metabolism factor for estimating the aggregate exposure to salicylic acid after dermal exposure of its esters","volume":"98","author":"Najjar","year":"2024","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2025.106019_bb0040","unstructured":"OECD. (2022). GUIDANCE NOTES ON DERMAL ABSORPTION STUDIES. https:\/\/one.oecd.org\/document\/ENV\/JM\/MONO(2011)36\/REV1\/en\/pdf (accessed 1 September, 2024)."},{"key":"10.1016\/j.tiv.2025.106019_bb0045","series-title":"Methyl salicylate: Determination of the dermal absorption through human skin in vitro (74751)","author":"RIFM","year":"2019"},{"key":"10.1016\/j.tiv.2025.106019_bb0050","series-title":"Opinion of the scientific committee on cosmetic products and non-food products intended for consumers concerning salicylic acid","author":"SCCNFP","year":"2002"},{"key":"10.1016\/j.tiv.2025.106019_bb0055","series-title":"OPINION on Homosalate","author":"SCCS","year":"2020"},{"key":"10.1016\/j.tiv.2025.106019_bb0060","series-title":"OPINION on Methyl salicylate (methyl 2-hydroxybenzoate)","author":"SCCS","year":"2021"},{"key":"10.1016\/j.tiv.2025.106019_bb0065","series-title":"Consumption Ratio and Food Predominance of Flavoring Materials","author":"Stofberg","year":"1987"},{"issue":"6","key":"10.1016\/j.tiv.2025.106019_bb0070","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1001\/archderm.1975.01630180068008","article-title":"Percutaneous absorption of salicylic acid","volume":"111","author":"Taylor","year":"1975","journal-title":"Arch. Dermatol."},{"issue":"8","key":"10.1016\/j.tiv.2025.106019_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13080934","article-title":"Human skin drug metabolism: relationships between methyl salicylate metabolism and esterase activities in IVPT skin membranes","volume":"13","author":"Telaprolu","year":"2023","journal-title":"Metabolites"},{"issue":"3","key":"10.1016\/j.tiv.2025.106019_bb0080","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.yrtph.2004.02.004","article-title":"In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: a multi-Centre comparison study","volume":"39","author":"van de Sandt","year":"2004","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.tiv.2025.106019_bb0085","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1208\/s12248-016-9984-0","article-title":"Mechanistic evaluation of hydration effects on the human epidermal permeation of salicylate esters","volume":"19","author":"Yousef","year":"2017","journal-title":"AAPS J."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088723332500013X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088723332500013X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T13:05:00Z","timestamp":1740488700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088723332500013X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":18,"alternative-id":["S088723332500013X"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2025.106019","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro human skin absorption of ethyl salicylate, pentyl salicylate, and (Z)-3-hexenyl salicylate from topical formulations: Effects on permeation and distribution","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2025.106019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106019"}}